Pivotal bioVenture Partners

VC San Francisco ·Founded 2017

Overview

Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies

Investment Focus

  • Innovative therapeutics addressing major unmet medical needs
  • Companies at all stages from seed to publicly listed entities
  • Strong management teams with transformative potential

Portfolio Companies

Karuna TherapeuticsVaxcyteEvommuneMaplight Therapeutics

Reach Pivotal bioVenture Partners directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Pivotal bioVenture Partners

What sectors does Pivotal bioVenture Partners invest in?

Pivotal bioVenture Partners invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in San Francisco. Pivotal bioVenture Partners is listed as a vc in the ConnectSafely investor database.

What stage does Pivotal bioVenture Partners invest at?

Pivotal bioVenture Partners backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.

Which regions does Pivotal bioVenture Partners invest in?

Pivotal bioVenture Partners invests across United States, United Kingdom, Germany, France, Italy and Denmark.

Who are the partners at Pivotal bioVenture Partners?

Team members listed for Pivotal bioVenture Partners include Karoly Nikolich (Venture Partner).

What companies has Pivotal bioVenture Partners invested in?

Pivotal bioVenture Partners's portfolio includes Karuna Therapeutics, Vaxcyte, Evommune and Maplight Therapeutics.

How do I contact Pivotal bioVenture Partners?

Pivotal bioVenture Partners's contact details — including phone — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database